← Insider buys
SRPT

Sarepta Therapeutics, Inc. · Healthcare

SVP Interim CEO, CMO Edward M. Md Kaye sold $737K of Sarepta Therapeutics, Inc.

Sold$736,710
$30.00Price
24,557Shares
−24%Stake

What SRPT did after the filing

Prices for SRPT after this filing aren't in yet.

Traded Wed, Sep 14. Filed Fri, Sep 16, 4:04 PM ET, after the close. Not investment advice.